| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |